InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,477.90
(
0.16%
)
US TECH 100
19,190.00
(
-0.13%
)
Dow Jones
39,127.80
(
0.04%
)
Brent Oil
84.75
(
0.33%
)
Bitcoin
61,064.47
(
0.41%
)
Post# of 252390
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

drbio45

Send PM Follow Ignore
Followers 36
Posts 3185
Boards Moderated 0
Alias Born 10/18/2003

drbio45

Re: rkrw post# 100455

Monday, 08/02/2010 5:38:26 PM

Monday, August 02, 2010 5:38:26 PM

Post# of 252390
It was a weak deal. Even with the low royalty rate the stock is priced so cheaply that the annual royalty is more than the market cap

You know everything. What are their funding needs? Servier is paying for the approval in Europe and the drug's develpment in Japan.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up